News Announcement

Natco Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release regarding the receipt of Establishment Inspection Report (EIR) for the API Unit of the Company located in Chennai from U.S. Food and Drugs Administration (FDA)

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.